(Press-News.org) ROCHESTER, Minn. -- Mayo Clinic researchers have found a way to detect and eliminate potentially troublemaking stem cells to make stem cell therapy safer. Induced Pluripotent Stem cells, also known as iPS cells, are bioengineered from adult tissues to have properties of embryonic stem cells, which have the unlimited capacity to differentiate and grow into any desired types of cells, such as skin, brain, lung and heart cells. However, during the differentiation process, some residual pluripotent or embryonic-like cells may remain and cause them to grow into tumors.
"Pluripotent stem cells show great promise in the field of regenerative medicine; however, the risk of uncontrolled cell growth will continue to prevent their use as a therapeutic treatment," says Timothy Nelson, Ph.D., M.D., lead author on the study, which appears in the October issue of STEM CELLS Translational Medicine.
Using mouse models, Mayo scientists overcame this drawback by pretreated stem cells with a chemotherapeutic agent that selectively damages the DNA of the stem cells, efficiently killing the tumor-forming cells. The contaminated cells died off, and the chemotherapy didn't affect the healthy cells, Dr. Nelson says.
"The goal of creating new therapies is twofold: to improve disease outcome with stem cell-based regenerative medicine while also ensuring safety. This research outlines a strategy to make stem cell therapies safer for our patients while preserving their therapeutic efficacy, thereby removing a barrier to translation of these treatments to the clinic," says co-author Alyson Smith, Ph.D.
Stem cell therapies continue to be refined and improved. Researchers are finding that stem cells may be more versatile than originally thought, which means they may be able to treat a wider variety of diseases, injuries and congenital anomalies. Stem cell therapy is an emerging regenerative strategy being studied at Mayo Clinic.
"By harnessing the potential of regenerative medicine, we'll be able to provide more definitive solutions to patients," says Andre Terzic, M.D., Ph.D., co-author and director of Mayo Clinic's Center for Regenerative Medicine.
###
Other members of the Mayo research team included Clifford Folmes, Ph.D., Katherine Hartjes, Natalie Nelson and Saji Oommen, Ph.D. The research was supported by the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, National Institutes of Health New Innovator Award OD007015-01, and a Mayo Clinic Center for Regenerative Medicine accelerated research grant.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about and www.mayoclinic.org/news
MULTIMEDIA ALERT: Video resources, including an interview with Dr. Nelson will be available for journalists at the Mayo Clinic News Network.
Mayo Clinic finds way to weed out problem stem cells, making therapy safer
2012-09-27
ELSE PRESS RELEASES FROM THIS DATE:
Scientists find molecular link to obesity and insulin resistance in mice
2012-09-27
BOSTON--Flipping a newly discovered molecular switch in white fat cells enabled mice to eat a high-calorie diet without becoming obese or developing the inflammation that causes insulin resistance, report scientists from Dana-Farber Cancer Institute.
The researchers say the results, to be published in the Sept. 28 issue of the journal Cell, provide the first known molecular link between thermogenesis (burning calories to produce heat) and the development of inflammation in fat cells.
These two processes had been previously thought to be controlled separately. Thermogenesis ...
Canadian science and technology is healthy and growing, says expert panel
2012-09-27
AUDIO:
An authoritative, evidence-based assessment of the state of science and technology in Canada has found that Canadian science and technology is healthy, growing and internationally respected. Over the past five...
Click here for more information.
Ottawa (September 27th, 2012) - An authoritative, evidence-based assessment of the state of science and technology in Canada has found that Canadian science and technology is healthy, growing and internationally respected. Over ...
Shared pathway links Lou Gehrig's disease with spinal muscular atrophy
2012-09-27
Researchers of motor neuron diseases have long had a hunch that two fatal diseases, amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), might somehow be linked. A new study confirms that this link exists.
"Our study is the first to link the two diseases on a molecular level in human cells," said Robin Reed, Harvard Medical School professor of cell biology and lead investigator of the study.
The results will be published online in the September 27 issue of Cell Reports.
ALS, or Lou Gehrig's disease, which has an adult onset, affects neurons that ...
Major cancer protein amplifies global gene expression, NIH study finds
2012-09-27
Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes of Health and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.
These findings, which will be published in Cell on Sept. 28, could lead to new therapeutic strategies for some cancers.
"We carried out a highly sophisticated ...
Obesity-related hormone discovered in fruit flies
2012-09-27
Researchers have discovered in fruit flies a key metabolic hormone thought to be the exclusive property of vertebrates. The hormone, leptin, is a nutrient sensor, regulating energy intake and output and ultimately controlling appetite. As such, it is of keen interest to researchers investigating obesity and diabetes on the molecular level. But until now, complex mammals such as mice have been the only models for investigating the mechanisms of this critical hormone. These new findings suggest that fruit flies can provide significant insights into the molecular underpinnings ...
Aggressive cancer exploits MYC oncogene to amplify global gene activity
2012-09-27
CAMBRIDGE, Mass. (September 27, 2012) – For a cancer patient, over-expression of the MYC oncogene is a bad omen.
Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.
The prevailing theory emerging from ...
Landmark guidelines for optimal quality care of geriatric surgical patients just released
2012-09-27
Chicago (September 27, 2012)—New comprehensive guidelines for the pre- operative care of the nation's elderly patients have been issued by the American College of Surgeons (ACS) and the American Geriatrics Society (AGS). The joint guidelines—published in the October issue of the Journal of the American College of Surgeons—apply to every patient who is 65 years and older as defined by Medicare regulations. The guidelines are the culmination of two years of research and analysis by a multidisciplinary expert panel representing the ACS and AGS, as well as by expert representatives ...
Uptick in cinematic smoking
2012-09-27
Top box office films last year showed more onscreen smoking than the prior year, reversing five years of steady progress in reducing tobacco imagery in movies, according to a new UCSF study.
Moreover, many of the top-grossing films of 2011 with significant amounts of smoking targeted a young audience, among them the PG-rated cartoon Rango and X-Men: First Class." The more smoking young people see in movies, the more likely they are to start smoking, the U.S. Surgeon General has reported.
The study will be available September 27, 2012 in Preventing Chronic Disease Journal, ...
Breakthrough in kitchen furniture production: Biocomposites challenge chipboard
2012-09-27
Biocomposites challenge chipboard as furniture material. Researchers at VTT Technical Research Centre of Finland have developed a kitchen furniture framework material from plastic polymers reinforced with natural fibre. The new material reduces raw materials consumption by 25 per cent and the carbon footprint of production by 35 per cent.
"The frames are lighter by nearly a third because they contain more air," says VTT's Research Professor Ali Harlin. "Wastage during production is also reduced. This is a generational shift that revolutionizes both manufacturing techniques ...
Breakthrough for new diabetes treatment
2012-09-27
In experiments on mice and rats, the scientists have managed to both prevent the development of type II diabetes and reverse the progression of established disease. The study is published in the prestigious scientific journal Nature, where it is described as a breakthrough in diabetes research. The findings are the result of a joint effort by Karolinska Institutet, the Ludwig Institute for Cancer Research and the Australian biopharmaceutical company CSL Limited, amongst others.
"It's a great feeling to present these results," says Professor Ulf Eriksson of the Department ...